A 36-year-old man, with newly diagnosed HIV infection and a CD~4~ T-cell count of 88 cells/mm^3^, presented with a 6-week history of malaise, weight loss, fever and a non-productive cough. Apart from weight loss, his clinical examination was unremarkable. A chest radiograph demonstrated bilateral nodular (\<1 mm) interstitial infiltrates suggestive of miliary tuberculosis. His liver aminotransferase enzymes were elevated but he was not jaundiced. Viral hepatitis serology confirmed HBeAg-positive chronic hepatitis B virus infection with a HBV DNA viral load of \>log 8.3 copies/ml. Given his constitutional symptoms and radiological findings, empiric standard 4 drug anti-tuberculous therapy was initiated.

His clinical course was complicated by persistent temperature spikes and the development of a diffuse erythematous maculopapular rash with central necrosis ([Image 1](#fig0005){ref-type="fig"}, [Image 2](#fig0010){ref-type="fig"}). Because of a lack of response to anti-TB therapy and a subsequent negative sputum GeneXpert^R^ result for *Mycobacterium tuberculosis*, his skin and liver were biopsied. [Image 3](#fig0015){ref-type="fig"}, [Image 4](#fig0020){ref-type="fig"} denote the liver biopsy findings of both hepatitis B and budding yeasts suggestive of histoplasmosis. No granulomas were observed. The skin biopsy was notable for the presence of apoptotic nuclear debris, no granulomas or vasculitis and small fungal yeasts palisading around superficial dermal capillaries ([Image 5](#fig0025){ref-type="fig"}, [Image 6](#fig0030){ref-type="fig"}).

Our working diagnosis was disseminated Histoplasmosis, however a blood culture yielded a yeast that was confirmed on molecular testing to be an emmonsia species [@bib0015].

Anti-TB therapy was stopped and intravenous amphotericin B was initiated as induction antifungal therapy. Two weeks later he was converted to oral Itraconazole. His fever resolved followed by a gradual resolution of the rash and clinical improvement. Appropriate antiretroviral therapy with tenofovir, emtricitabine and efavirenz to manage his HIV-Hepatitis B co-infection was initiated upon completion of the 2 weeks of intravenous amphotericin B [@bib0020].

Disseminated fungal infections should be suspected in patients with advanced HIV/AIDS that present with systemic illness. A new dimorphic fungus related to *Emmonsia pasteuriana* has recently been identified at our institution and is the likely pathogen in our patient [@bib0015].

The case highlights the value of the early use of appropriate diagnostic techniques in patients with advanced HIV/AIDS and multi-systemic illness given the many differential diagnoses in such patients. The patient continues to do well in follow up.

![Diffuse erythematous maculopapular rash.](gr1){#fig0005}

![Close-up view of skin rash noting central necrosis.](gr2){#fig0010}

![Needle biopsy of the liver showing ground-glass hepatocytes, microvesicular steatosis and haemosiderin pigment in Kupffer cells with minimal necroinflammatory activity (H&E; high power magnification).](gr3){#fig0015}

![Needle biopsy of the liver showing small fungal yeasts in the cytoplasm (arrow) of portal tract macrophages (PAS/diastase; high power magnification).](gr4){#fig0020}

![Skin punch biopsy showing nuclear debris from apoptotic neutrophils around a capillary in the superficial dermis (H&E; high power magnification).](gr5){#fig0025}

![Skin punch biopsy demonstrating small fungal yeasts with narrow-based budding present in the dermis (Grocott silver stain; high power magnification).](gr6){#fig0030}
